Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone

The Journal of Clinical Investigation
R J LewisW L Schary

Abstract

An examination of the metabolic fate of the R and the S isomers of warfarin revealed that the two isomers were metabolized by different routes. R warfarin was oxidized to 6-hydroxywarfarin and was reduced to the (R,S) warfarin alcohol. In contrast, S warfarin was oxidized to 7-hydroxywarfarin and was reduced to the (S,S) warfarin alcohol. S warfarin was also oxidized to 6-hydroxywarfarin. These observations suggested that interactions between warfarin and other drugs might be manifest stereo-specifically, i.e., have a different effect on the isomers of warfarin, so a series of experiments were conducted with each isomer of warfarin, before and after phenylbutazone. The plasma clearance of S warfarin was slowed from 3.1 to 1.1% per h in one subject and from 2.3 to 1.6% per h in another. In contrast, the clearance of R warfarin was increased from 1.5 to 3.0% per h and from 0.9 to 1.6% per h in two subjects after phenylbutazone. The rate of clearance of racemic warfarin was unaffected by phenylbutazone; the depression of the rate of clearance of the S isomer masked the stimulation of the clearance of the R isomer. Since S warfarin is five times more potent an anticoagulant than R warfarin, it is concluded that inhibition of the me...Continue Reading

References

Jun 1, 1973·The Journal of Pharmacy and Pharmacology·D S Hewick, J McEwen
Dec 1, 1972·Journal of Medicinal Chemistry·K K ChanW F Trager
Mar 1, 1972·European Journal of Clinical Pharmacology·C F GeorgeC T Dollery
Apr 8, 1972·Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology·A M Breckenridge, M L Orme
May 1, 1970·The Journal of Clinical Investigation·R J Lewis, W F Trager
Nov 1, 1970·Journal of Medicinal Chemistry·W F TragerW A Garland
May 1, 1970·Biochemical Pharmacology·A K ChoB B Brodie
Mar 2, 1967·The New England Journal of Medicine·P M AggelerP E Kowitz
Jul 7, 1967·Biochemical Pharmacology·H M Solomon, J J Schrogie
Oct 26, 1967·The New England Journal of Medicine·J B FieldA Remer
Jul 8, 1964·Biochimica Et Biophysica Acta·M GOLDSTEINE LAUBER

Citations

May 1, 1977·Journal of Clinical Pharmacology·K A BachmannJ Mackiewicz
Feb 1, 1996·Journal of Clinical Pharmacology·H ShimodairaT Kudo
Jan 1, 1992·European Journal of Clinical Pharmacology·H G EichlerA Korn
Jan 1, 1993·European Journal of Clinical Pharmacology·C Mieszczak, K Winther
Aug 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·K J FehskeA Stillbauer
Jan 1, 1982·European Journal of Clinical Pharmacology·J O MinersD J Birkett
Jan 1, 1982·European Journal of Clinical Pharmacology·J O MinersD J Birkett
Oct 15, 1978·Experientia·J C McElnay, P F D'Arcy
Jan 1, 1997·European Journal of Clinical Pharmacology·D TürckJ Hoffmann
Nov 27, 2009·Journal of Pharmacokinetics and Pharmacodynamics·Eunice YuenL J Aarons
Oct 1, 1976·Biochemical Pharmacology·L R PohlJ W Fenton
Jan 1, 1981·Pharmacology & Therapeutics·L J Aarons
Jan 1, 1987·Pharmacology & Therapeutics·R O DayJ de Jager
Jan 1, 1988·Pharmacology & Therapeutics·J C Mucklow
Jan 1, 1990·Pharmacology & Therapeutics·M Barry, J Feely
Jan 1, 1990·Acta Pharmaceutica Nordica·G T Tucker
Dec 9, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Qingyu Zhou, E Chan
Dec 3, 2013·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Osama Y AlshogranThomas D Nolin
Aug 18, 1979·Lancet·M J SerlinJ M Willoughby
Jan 1, 1997·Pharmacology & Therapeutics·L S Kaminsky, Z Y Zhang
May 14, 2003·Journal of the American College of Cardiology·Jack HirshAmerican Heart Association/American College of Cardiology Foundation
Oct 3, 2002·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Qingyu Zhou, E Chan
May 16, 1998·Trends in Microbiology·A Casadevall
Jul 15, 1998·British Journal of Clinical Pharmacology·J O Miners, D J Birkett
Dec 18, 2002·Journal of Veterinary Pharmacology and Therapeutics·P L Toutain, A Bousquet-Melou
Aug 12, 1976·The New England Journal of Medicine·R O'Reilly
Jun 27, 1991·The New England Journal of Medicine·Jack Hirsh
Aug 1, 1974·British Journal of Clinical Pharmacology·A M Breckenridge
Feb 1, 1978·British Journal of Clinical Pharmacology·T MeinertzE Jähnchen
May 1, 1978·British Journal of Clinical Pharmacology·E JähnchenU Groth
Nov 1, 1978·British Journal of Clinical Pharmacology·L B Wingard, G Levy
Sep 1, 1979·British Journal of Clinical Pharmacology·P A RoutledgeM D Rawlins
Aug 1, 1991·British Journal of Clinical Pharmacology·Y H ParkR K Brazzell
Oct 1, 1991·British Journal of Clinical Pharmacology·I NiopasM Rowland
Jun 1, 1994·British Journal of Clinical Pharmacology·E ChanM Rowland
Mar 1, 1978·Clinical and Experimental Pharmacology & Physiology·K HotraphinyoA Maclaine-Cross
Aug 1, 1975·Australian and New Zealand Journal of Medicine·S M PondG Sudlow
Nov 1, 1975·The Journal of Pharmacy and Pharmacology·K A Bachmann, A M Burkman
May 1, 1977·The Journal of Pharmacy and Pharmacology·W Schmidt, E Jähnchen
May 1, 1979·The Journal of Pharmacy and Pharmacology·L J AaronsM Rowland
Feb 21, 1976·British Medical Journal·A M Breckenridge
Mar 1, 1980·The Journal of Clinical Investigation·R O'ReillyW N Howald
Nov 1, 1985·The Journal of Clinical Investigation·P H Hsyu, K M Giacomini
Apr 18, 2001·Journal of Clinical Pharmacology·K MatsumotoM Shibakawa
Jan 1, 1987·Reviews on Drug Metabolism and Drug Interactions·F A SutcliffeG G Gibson
Jan 14, 2003·Pharmacotherapy·Markus G GebauerAlexander S Gallus
Nov 13, 2002·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·O Rehulková
Feb 14, 2009·American Journal of Pharmaceutical Education·Jorge Duconge
Jan 1, 1986·European Journal of Clinical Pharmacology·J X de VriesJ Harenberg
Nov 1, 2013·Drug Metabolism Reviews·Petra Malátková, Vladimír Wsól
Apr 13, 2011·Expert Opinion on Drug Metabolism & Toxicology·Drew R Jones, Grover P Miller
Mar 1, 1991·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J J Hermans, H H Thijssen
Dec 17, 2015·Pharmacogenomics·Addepalli PavaniVijay Kumar Kutala
Jul 20, 2005·Journal of Clinical Pharmacology·Nishit B ModiRamon Vargas
May 21, 2003·British Journal of Clinical Pharmacology·Michel Eichelbaum
Jun 26, 2008·Pharmacotherapy·James J ZimmermanJohn L Speth
Aug 9, 1993·The American Journal of Medicine·D E HillemanB D Lucas
Oct 1, 1991·Seminars in Arthritis and Rheumatism·D S Newcombe
Aug 1, 1980·Journal of Clinical Pharmacology·T G TongM J Kreek
Mar 1, 1981·British Journal of Clinical Pharmacology·B WhitingD S Robins
Nov 1, 1981·British Journal of Clinical Pharmacology·J GodbillonE Jähnchen
May 1, 1984·British Journal of Clinical Pharmacology·A K ScottA M Breckenridge
Apr 9, 2016·Biochemical Pharmacology·Petra MalátkováVladimír Wsól
May 12, 2009·Drug Metabolism and Pharmacokinetics·Tae InoueShigeru Ohta
Feb 26, 2016·Journal of Analytical Toxicology·Zane Z HauckRichard B van Breemen
Oct 1, 1980·Toxicology and Applied Pharmacology·M J Fasco, M J Cashin
Aug 1, 1988·Baillière's Clinical Rheumatology·D E Furst
Jan 1, 1991·Scandinavian Journal of Rheumatology. Supplement·G R Hughes
Oct 1, 1977·Journal of Pharmacokinetics and Biopharmaceutics·T D BjornssonT F Blaschke
Apr 2, 2003·Circulation·Jack HirshAmerican College of Cardiology Foundation
Jul 1, 1984·Medicinal Research Reviews·M Simonyi
Jan 1, 1976·Annals of the New York Academy of Sciences·G Levy
Jan 1, 1976·Annals of the New York Academy of Sciences·A Hurwitz, D L Azarnoff
Mar 19, 2005·Biopharmaceutics & Drug Disposition·Xuan Zhu, Wan G Shin
May 1, 1989·Epilepsia·H VorumR Brodersen
Apr 6, 2019·Expert Opinion on Drug Metabolism & Toxicology·Ameenathul M Fawzy, Gregory Y H Lip
Jan 1, 1980·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R E BillingsR E McMahon
Jun 25, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Dustyn A BarnetteGrover P Miller
Dec 1, 1979·Journal of Pharmacokinetics and Biopharmaceutics·W Schmidt, E Jähnchen
Jan 1, 1984·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A R Boobis, D S Davies
Dec 13, 2012·Journal of Cardiovascular Pharmacology·Masanori AbeMasayoshi Soma
Mar 1, 1986·British Journal of Clinical Pharmacology·I A ChoonaraB K Park
Oct 1, 1996·Journal of Clinical Psychopharmacology·A T Harvey, S H Preskorn
Jul 1, 1985·Drug Intelligence & Clinical Pharmacy·R S RhodesC D Sintek
Dec 1, 1983·The Journal of Pharmacy and Pharmacology·H H ThijssenM J Reijnders
May 1, 1992·The Annals of Pharmacotherapy·M Gibaldi
Dec 1, 1995·The Annals of Pharmacotherapy·L A Frazee, M D Reed
Apr 1, 1977·Journal of Pharmacokinetics and Biopharmaceutics·A Yacobi, G Levy
Jan 1, 1989·Scandinavian Journal of Rheumatology. Supplement·M E Weinblatt
Dec 1, 1983·British Journal of Clinical Pharmacology·C BanfieldM Rowland
Apr 1, 1989·British Journal of Clinical Pharmacology·T S GillM Rowland
Oct 1, 1980·The Journal of Pharmacy and Pharmacology·J C McElnay, P F D'Arcy
Aug 1, 1996·Journal of Clinical Psychopharmacology·A T Harvey, S H Preskorn
Jan 1, 1980·Biomedical Mass Spectrometry·W N HowaldC H Motley
Nov 1, 1984·Drug Intelligence & Clinical Pharmacy·B WeinerL Swanson
Jul 6, 2019·Journal of Clinical Pharmacology·Jacqueline RamírezManish R Sharma
Jul 1, 1982·The Journal of Pharmacy and Pharmacology·H SatohS Satoh

Related Concepts

Blood Coagulation
Thin Layer Chromatography
Drug Interactions
Total Body Clearance Rate
Oxidation-Reduction
Fenilbutazon
Plasma Protein Binding Capacity
Thrombotest
Molecular Stereochemistry
Gen-Warfarin

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.